Table 2A. Baseline demographics and patient characteristics (n=44).
|
Age, years | |
| Median | 64.5 |
| Range | 48–83 |
|
Sex, n (%) | |
| Male | 35 (79.5) |
| Female | 9 (20.5) |
|
Race or ethnic background, n (%) | |
| White | 41 (93.2) |
| Black | 2 (4.5) |
| Othera | 1 (2.3) |
|
ECOG score, n (%) | |
| 0 | 11 (25) |
| 1 | 33 (75) |
|
Tumour type, n (%) | |
| Colorectal | 14 (32) |
| Prostate | 9 (20) |
| Hepatocellular | 6 (14) |
| Bladder | 2 (4.5) |
| Lung | 2 (4.5) |
| Pancreas | 2 (4.5) |
| Unknown primary | 2 (4.5) |
| Otherb | 7 (16) |
|
Previous therapies, n (%) | |
| Surgeryc | 28 (63.6) |
| Radiotherapy | 23 (52.3) |
| Systemic therapyd | 44 (100) |
Abbreviation: ECOG=Eastern Cooperative Oncology Group.
a
Eastern European.
b
Other tumour types included one each of adenocarcinoma, cholangiocarcinoma, endometrial, esophagus, head and neck, renal cell and urothelial.
c
Surgery excludes biopsy, aspiration and paracentesis.
d
System therapy included hormonal, biologic, chemotherapy and other systemic therapy.